Explore / Clinical trial
Clinical trial

Pediatric Spinal Muscular Atrophy (SMA) China Registry

BiogenActive, not recruitingStarted Nov 18, 2021600 enrolledChinaNCT05042921

Abstract

The primary objective of the study is to describe the natural history and utilization of disease modifying therapy (DMT) treatments among pediatric Chinese participants with spinal muscular atrophy linked to chromosome 5q (5q-SMA). The study will examine SMA natural history and DMT outcomes in a real-world setting both prospectively and retrospectively.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

DMT

Keywords

Muscular Atrophy, Spinal

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.